Retraction Note: Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells (Scientific Reports, (2015), 5, 1, (10665), 10.1038/srep10665);Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liu, Jiang Qi ^a,c,d   Li, Xing Yong ^b   Yu, Hai Qiong ^a   Yang, Gui ^a,c,d   Liu, Zhi Qiang ^a,c,d   Geng, Xiao Rui ^a,c,d   Wang, Shuai ^a,c   Mo, Li Hua ^a   Zeng, Lu ^a   Zhao, Miao ^a,c,d   Fu, Yun Ting ^a,c,d   Sun, Hong Zhi ^a   Liu, Zhi Gang ^a   Yang, Ping Chang ^a,d  

^a Shenzhen University School of Medicine   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

^c Longgang Central Hospital   (China)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL; APOPTOSIS; COLON TUMOR; DISEASE MODEL; HELPER CELL; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PATHOLOGY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84934882123     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-021-92334-5     Document Type: Erratum

References (27)

1. Zitvogel, L., Tesniere, A. & Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 6, 715-727 (2006
2. Karanikas, V. & Germenis, A. Tumor specific CD8+ T cells in patients with lung cancer and healthy individuals. J buon 14 Suppl 1, S153-157 (2009
3. Chuang, S. S. & Ko, Y. H. Cutaneous nonmycotic T-And natural killer/T-cell lymphomas: diagnostic challenges and dilemmas. J Am Acad Dermatol 70, 724-735 (2014
4. Fridman, W. H., Mlecnik, B., Bindea, G., Pages, F. & Galon, J. Immunosurveillance in human non-viral cancers. Curr Opin Immunol 23, 272-278 (2011
5. Jackaman, C. & Nelson, D. J. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts? Exp Gerontol 54, 53-57 (2014
6. Lutsiak, M. E., et al. Inhibition of CD4(+ )25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105, 2862-2868 (2005
7. Ghiringhelli, F., et al. Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 56, 641-648 (2007
8. Hung, K., et al. The central role of CD4(+ ) T cells in the antitumor immune response. J Exp Med 188, 2357-2368 (1998
9. Corthay, A., et al. Primary antitumor immune response mediated by CD4+ T cells. Immunity 22, 371-383 (2005
10. Cervero, F. Noxious intensities of visceral stimulation are required to activate viscerosomatic multireceptive neurons in the thoracic spinal cord of the cat. Brain Res 240, 350-352 (1982
11. Lu, Y. & Yi, Q. Utilizing T9 cells as a novel therapeutic strategy for malignancies. Oncoimmunology 2, e23084 (2013
12. Wu, S., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15, 1016-1022 (2009
13. Kryczek, I., et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114, 1141-1149 (2009
14. Kennedy, R. & Celis, E. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev 222, 129-144 (2008
15. Kitajima, M., et al. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells. Cancer Res 71, 4790-4798 (2011
16. Purwar, R., et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18, 1248-1253 (2012
17. Srivastava, K., et al. Immunomodulatory effect of the antiasthma Chinese herbal formula MSSM-002 on TH2 cells. J Allergy Clin Immunol 113, 268-276 (2004
18. Mohankumar, K., et al. Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin--An in vitro and in silico approach. Chem Biol Interact 210, 51-63 (2014
19. Wang, B. Q., et al. Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance. J Cancer Res Clin Oncol 137, 1525-1533 (2011
20. Wu, H., et al. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients. J Gastroenterol Hepatol 28, 1555-1564 (2013
21. Zhang, L. L., et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 25, 928-934 (2010
22. Chu, D. K., et al. T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and independent of innate-like lymphocytes. Mucosal Immunol 7, 1395-1404 (2014
23. Dardalhon, V., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9, 1347-1355 (2008
24. Feng, B. S., et al. Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allergy Clin Immunol 122, 55-61, 61.e51-57 (2008
25. He, W., et al. CD4(+ ) T cells from food allergy model are resistant to TCR-dependent apoptotic induction. Cytokine 68, 32-39 (2014
26. Post, S., et al. Protease-Activated receptor-2 activation contributes to house dust mite-induced IgE responses in mice. PLoS One 9, e91206 (2014
27. Foro, P., et al. Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study. Int J Radiat Oncol Biol Phys 88, 1057-1063 (2014).